Academic · Private company
Beyond Batten Disease Foundation
Track this companyFree. Adds Beyond Batten Disease Foundation to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials2
- Study With Batten-1 (Miglustat Liquid Formulation) to Treat Ceroid Lipofuscinosis Neuronal 3 (CLN3) DiseasePHASE3 · NOT_YET_RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07882290 · fetched Nov 12, 2026
- An Open-label Safety, Pharmacokinetic, and Efficacy Study of Miglustat for the Treatment of Subjects With Batten Ceroid Lipofuscinosis, Neuronal 3 (CLN3) DiseasePHASE1_PHASE2 · COMPLETED · started Mar 10, 2022ClinicalTrials.gov NCT05174039 · fetched Nov 12, 2026